Yahoo Finance

Elite Pharmaceuticals, Inc. Issues Statement on Product Approval Listing

NORTHVALE, NJ / ACCESSWIRE / November 24, 2020 / Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCQB:ELTP) received inquiries about a recent ANDA approval listing for ...
Yahoo Finance

Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information

NORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty pharmaceutical company engaged in the development, manufacture, and ...
Seeking Alpha

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information

Northvale, New Jersey--(Newsfile Corp. - August 14, 2025) - Elite Pharmaceuticals, Inc. (ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, ...
Nasdaq

Elite Pharmaceuticals Gains FDA Approval for Generic Vyvanse

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...
Fox2Now St. Louis

Elite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officer

NORTHVALE, NJ / ACCESSWIRE / September 7, 2023 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing and manufacturing niche generic ...
Hosted on MSN

Elite Pharmaceuticals to Release Q2 2026 Results Soon

Elite Pharmaceuticals ( (ELTP)) has provided an announcement. Elite Pharmaceuticals announced that it will release its second quarter financial results for the fiscal year 2026 on November 14, 2025, ...
Nasdaq

Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information

The financial statements can be viewed for Elite's Second Quarter of Fiscal Year 2024 on Form 10-Q here. This press release contains "forward-looking statements" within the meaning of the Private ...
Seeking Alpha

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information

Northvale, New Jersey--(Newsfile Corp. - June 30, 2025) - Elite Pharmaceuticals, Inc. (ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced ...
MarketWatch

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information

The MarketWatch News Department was not involved in the creation of this content. Northvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or ...
Finanznachrichten

Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information

Conference Call Scheduled for Thursday, February 15 at 11:30 AM EST NORTHVALE, NJ / ACCESSWIRE / February 14, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCBB:ELTP), a specialty ...
Mena FN

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2026 Ended September 30, 2025 And Provides Conference Call Information

(MENAFN- Newsfile Corp) Northvale, New Jersey--(Newsfile Corp. - November 14, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company ...